Bayview Legacy, LLC

Bayview Legacy, LLC has been a consistent seller of its stake in Arteris, Inc. (AIP), with SEC Form 4 filings showing 37 total transactions, all involving a single company. The entity has recorded zero open-market purchases and zero acquisitions, while executing $35.38 million in open-market sales. This one-directional pattern is unambiguous: every transaction with a monetary value reflects a disposition of shares, with no corresponding accumulation. The selling activity has been concentrated and recent. In the first week of July 2026 alone, Bayview Legacy filed 14 separate Form 4s reporting sales of AIP stock, with individual transaction values ranging from roughly $101,958 to $2.80 million. The largest single-day activity occurred on July 2, when the entity reported eight sales totaling approximately $7.88 million. That followed July 1 sales of about $8.24 million and a July 6 cluster of three sales worth approximately $4.51 million. Earlier in the year, the entity sold smaller blocks in March, April, May, and June, with values ranging from $126,432 to $2.18 million. Two gift transactions, valued at zero, were also recorded in February and May. The data shows no recent buying bias whatsoever—the last 23 transactions were all open-market sales. The pattern is one of steady, systematic liquidation of a concentrated position in AIP, with the pace accelerating sharply in the most recent reporting period. Bayview Legacy has not acquired a single share through open-market purchases, grants, or option exercises during the covered period, making the selling pressure entirely one-sided.